Productivity and attrition: key challenges for biotech and pharma
- 17 June 2003
- journal article
- editorial
- Published by Elsevier in Drug Discovery Today
- Vol. 8 (12) , 513-515
- https://doi.org/10.1016/s1359-6446(03)02658-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Trends in microarray analysisNature Medicine, 2003
- Using Cyclooxygenase-2 Inhibitors as Molecular Platforms to Develop a New Class of Apoptosis-Inducing AgentsJNCI Journal of the National Cancer Institute, 2002
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Bio- and chemo-informatics beyond data management: crucial challenges and future opportunitiesDrug Discovery Today, 2002
- Fuelling the pipelineNature Reviews Drug Discovery, 2002
- Realism in drug discovery—could Cassandra be right?Nature Biotechnology, 2001
- Research suggests importance of haplotypes over SNPsNature Biotechnology, 2000
- A chemistry set for lifeNature, 2000